Search PDMR transactions

Notifier
Name of person with notification obligation
Mats Blom
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Mats Blom
Position
Chairman of the Board of Directors
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Egetis Therapeutics AB (publ)
Issuer´s LEI code
549300RZCKGWRUBPMY22
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Egetis Therapeutics AB SE0003815604 Acquisition 150,000 Quantity 4.48 SEK 14/01/2026 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Egetis Therapeutics AB SE0003815604 Acquisition 14/01/2026 NASDAQ STOCKHOLM AB 150,000 (Quantity) 4.48 SEK
Total: 150,000
<< Back